Trial Profile
Phase II trial of avibactam/ceftaroline fosamil
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2009
Price :
$35
*
At a glance
- Drugs Avibactam/ceftaroline fosamil (Primary)
- Indications Bacterial infections; Systemic inflammatory response syndrome; Urinary tract infections
- Focus Therapeutic Use
- Sponsors AstraZeneca; Novexel
- 29 Dec 2009 New trial record.